Immunologist calls for universal access to drug that prolonged Vicky Phelan's life

Vicky Phelan credited Pembrolizumab with having given her three more years than she would have expected if she had just stayed on chemotherapy. Picture: Naomi Gaffey

One of Ireland’s leading immunologists has called for universal access to a drug that prolonged the life of cancer campaigner Vicky Phelan.

Professor Bernard Mahon, who has late stage stomach cancer, was initially refused access to treatment with Pembrolizumab by his private health insurer.